Extraskeletal myxoid chondrosarcoma of maxilla: A rare entity.

J Oral Maxillofac Pathol

Department of Oral Pathology and Microbiology, Sinhgad Dental College and Hospital, Pune, Maharashtra, India.

Published: May 2016

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860919PMC
http://dx.doi.org/10.4103/0973-029X.180980DOI Listing

Publication Analysis

Top Keywords

extraskeletal myxoid
4
myxoid chondrosarcoma
4
chondrosarcoma maxilla
4
maxilla rare
4
rare entity
4
extraskeletal
1
chondrosarcoma
1
maxilla
1
rare
1
entity
1

Similar Publications

Introduction: Percutaneous cryoablation is a first-line therapeutic option for primary neoplasms and metastatic lesions of the musculoskeletal system. Treatment of abdominal wall tumors is challenging as surgical resection can be highly morbid and necessitate complex reconstructive surgery; the efficacy of cryoablation for abdominal wall tumors may be limited by inadequate posterior margins owing to the proximity of intra-abdominal organs. With laparoscopy and insufflation, peritoneal structures can be safely mobilized away from the abdominal wall, allowing for adequate deep margin freeze and visualization of the ice ball.

View Article and Find Full Text PDF

Clinical, imaging and pathological features of extraskeletal myxoid chondrosarcoma.

Skeletal Radiol

September 2024

Division of Musculoskeletal Imaging and Intervention, Department of Radiology, Massachusetts General Hospital, Yawkey 6E 55 Fruit Street, Boston, MA, 02114, USA.

Objective: To evaluate clinical and radiological features of extraskeletal myxoid chondrosarcomas (EMC).

Material And Methods: Our pathology database was queried for cases of EMCs. Tumor location, size, imaging appearance, presence of metastases, disease recurrence, and clinical outcome were documented.

View Article and Find Full Text PDF

Four primary extraskeletal osteosarcomas of the pleura are presented. The patients were men between the ages of 63 and 78 years (average: 70.5 years) who presented with symptoms of chest pain, cough, and shortness of breath.

View Article and Find Full Text PDF

Whole genome sequencing for metastatic mutational burden in extraskeletal myxoid chondrosarcoma.

Front Mol Med

July 2023

Musculoskeletal Oncology Laboratory, Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.

Extraskeletal myxoid chondrosarcoma (EMC) is an ultra-rare cancer that makes up less than 3% of all soft tissue sarcomas. It most often arises in the soft tissues of the proximal limbs and has a higher incidence in males. Though EMC has a good prognosis, it has an indolent course with high rates of local recurrence as well as metastasis to the lungs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!